Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine

NCT00977899 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.

NCT NCT00977899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase
Phase 1
Overall status
Withdrawn
Start date
August 20, 2009
Completion date
March 5, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria vaccines, plasmodium falciparum malaria